Clinical Research Participation
What is a clinical trial and why do people participate?
Clinical trials look at new ways to prevent, detect and treat disease. Treatments might be new drugs or new combination of drugs or new ways to use existing treatments.
People with an illness or disease participate to help others, but also to possibly receive the newest treatment and have the additional care and attention from clinical trial staff.
Who participates in clinical trials and do I qualify?
The Corning Center for Clinical Research recruits patient volunteers who have a known allergy, asthma or pulmonary health problem, enabling us to better understand the effectiveness of a particular treatment. All clinical trials have guidelines about who can participate, factors such as age, gender, type and stage of disease, previous treatment history and other medical conditions may apply. A summary of inclusion/exclusion criteria is listed for each study (see tabs above for list of studies), and detailed information is available at no charge by contacting Tracey Loid, Study Coordinator (connection to CCCR staff page) Tracey@SmithAllergy.com or call 607.684.6115.
Is a Clinical Trial safe for me?
At the Corning Center for Clinical Research, we focus on testing new treatments, new drugs and new combinations of drugs, at the Phase III trial level, where the experimental drug or treatment is administered to a large group of people (1,000–3,000 people) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatments, and collect data that will allow the experimental drug or treatment to be used safely.
We follow FDA approved protocols that are carefully designed to safeguard your health. All clinical studies are led by our principal investigator, Dr. Christopher Smith and approved by Central Institutional Review Boards to ensure that the risks are minimal and are worth any potential benefits. Institutional Review Boards are comprised of physicians, statisticians and members of the medical community whose purpose is to ensure that clinical trials are performed ethically and that your rights as a participant are protected.
Informed consent keeps you in the know.
We provide you with the key facts about a clinical trial before you decide to participate, and on an ongoing basis throughout the study. You can rely on the Corning Center for Clinical Research team to thoroughly explain study details so you have all the information you need to make an informed decision to participate. You will receive an informed consent document detailing all aspects of the study— its purpose, duration, required procedures, and who to contact for further information. You are free to withdraw from the study or to refuse particular treatments or tests at any time, understanding, however, that this will make you ineligible to continue the study.
What questions should I ask if offered a clinical trial?
If you think you might want to participate in a clinical trial, feel free to ask any questions. The following thought starters may give you some ideas as you formulate your own questions.
What is the purpose of the study?
How long will the study last?
What will my responsibilities be if I participate?
Participation and care
What kinds of therapies, procedures and /or tests will I have during the trial?
Will I be able to take my regular medications while in the clinical trial?
Where will I have my medical care?
Cost & Compensation
Will I have to pay for any part of the trial such as tests or the study drug?
What is my health insurance likely to cover?
Will I be compensated for my time and travel costs?
IN THE END WHAT HAPPENS?
Once your clinical trial is finished, researchers will thoroughly analyze data collected during the study, including whether or not further testing is warranted. Once a clinical trial proves a new approach to be safe and effective, it may become the medical standard. You are welcome to contact Corning Center for Clinical Research to find out if study results have been or will be published.
We want to talk to you. Please contact:
Tracey Loid, Study Coordinator – Tracey@SmithAllergy.com 607.684.6115